"Designing Growth Strategies is in our DNA"

DNA Modifying Enzymes Market Size, Share & Industry Analysis, By Source (Microbial and Animal), By Type (DNA Ligases {T7 DNA, T4 DNA, and Others}), DNA Polymerases, Exonucleases {Exonucleases I, Exonucleases II, and Others}, Endonucleases {DNase I and Others}, Methyltransferase, Inorganic Pyrophosphatase, and Others), By Application (Genomics & Genetic Engineering, Drug Discovery & Research, and Others), By End-user (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI110796

 


DNA Modifying Enzymes Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 167
  • Buy Now

    (Offer valid till 15th Dec 2025)

Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann